tiletamine hydrochloride has been researched along with Carcinoma, Squamous Cell in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Han, J; Li, C; Ma, J; Shi, S; Wang, Q; Yang, H | 1 |
| Kondo, S; Mukudai, Y; Nagumo, T; Shintani, S; Tsukamoto, H; Umezawa, K; Yasuda, A | 1 |
| Ito, A; Komune, S; Kuratomi, Y; Masuda, M; Nakashima, T; Ruan, HY; Umezawa, K; Weinstein, IB; Yamamoto, T; Yasumatsu, R | 1 |
3 other study(ies) available for tiletamine hydrochloride and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
Integrative Pathway Analysis of Genes and Metabolites Reveals Metabolism Abnormal Subpathway Regions and Modules in Esophageal Squamous Cell Carcinoma.
Topics: beta-Alanine; Biphenyl Compounds; Carcinoma, Squamous Cell; Chromatography, Liquid; Cyclohexanones; Cytochrome P-450 CYP2C8; Cytochrome P-450 Enzyme System; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Liver; Microsomes; Protein Isoforms; Tandem Mass Spectrometry | 2017 |
Anti-tumor activity of dehydroxymethylepoxyquinomicin against human oral squamous cell carcinoma cell lines in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Benzamides; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cyclohexanones; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Inhibitor of Apoptosis Proteins; Mice; Mouth Neoplasms; NF-kappa B; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured | 2011 |
Effects of a novel NF-kappaB inhibitor, dehydroxymethylepoxyquinomicin (DHMEQ), on growth, apoptosis, gene expression, and chemosensitivity in head and neck squamous cell carcinoma cell lines.
Topics: Apoptosis; Benzamides; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclohexanones; Gene Expression; Head and Neck Neoplasms; Humans; NF-kappa B; Vascular Endothelial Growth Factor A | 2006 |